The relationship between genotype and chromosome aberration frequencies in a normal adult population

Pharmacogenetics

Volumn 10, Issue 4, 2000, Pages 311-319

  Pluth, Janice M ^a   Nelson, David O ^a   Ramsey, Marilyn J ^a   Tucker, James D ^a  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Chromosome aberration frequency; Chromosome painting; Genotype; Normal adult population

Indexed keywords

ACYLTRANSFERASE; CYTOCHROME P450 ISOENZYME; DNA; EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE;

ACETYLATOR PHENOTYPE; ARTICLE; CANCER RISK; CHROMOSOME ABERRATION; DNA POLYMORPHISM; ENZYME POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; MALE; MUTATION RATE; NORMAL HUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SMOKING;

EID: 0034088504     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200006000-00005     Document Type: Article

References (36)

1. Abdel-Rahman SZ, El-Zein RA, Zwischenberger JB, Au WW. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers. Mutat Res 1998; 398:43-54.
2. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JH, Brasure JR, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995; 55:3483-3485.
3. Bailey LR, Roodi N, Verrier CS, Yee CJ, Dupont WD, Parl FF. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res 1998; 58:65-70.
4. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Luciér GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst 1993; 85:1159-1164.
5. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, et al. Are chromosome aberrations in circulation lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 1995; 79:133-135.
6. Brockmöller J, Cascorbi I, Kerb R, Roots I. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996; 56:3915-3925.
7. Cascorbi I, Brockmoller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996; 56:3961-3966.
8. Chen H, Sandler DP, Taylor JA, Shore DL, Liu E, Bloomfield CD, Bell DA. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996; 347:295-297.
9. Cholerton S, Boustead C, Taber H, Arpanahi A, Idle JR. CYP2D6 genotypes in cigarette smokers and non-tobacco users. Pharmacogenetics 1996; 6:261-263.
10. Deitz AC, Doll MA, and Hein DW. A restriction fragment-length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Analyt Biochem 1998; 253:219-224.
11. Doll M, Fretland A, Deity A, Hein D. Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification. Analyt Biochem 1995; 231:413-420.
12. Fryer AA, Zhao L, Alldersea J, Boggild MD, Perrett CW, Clayton RN, et al. The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM10 genotype in patients with pituitary adenomas. Carcinogenesis 1993; 14:563-566.
13. Gil JP, Lechner MC. Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis 1998; 19:37-41.
14. Grant DM, Josephy PD, Lord HL, Morrison LD. Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines. Cancer Res 1992; 52:3961-3964.
15. Hagmar L, Bragger A, Hansteen IL, Heim S, Hogstedt B, Knudsen LE, et al. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 1994; 54:2919-2922.
16. Hagmar L, Bonassi S, Stromberg U, Brogger A, Knudsen LE, Norppa H, Reuterwall C. and the European Study Group on Cytogenetic Biomarkers and Health. Chromosomal aberrations in lymphocytes predict human cancer: a report from the European Study Group on Cytogenetic Biomarkers and Heath (ESCH). Cancer Res 1998a: 58:4117-4121.
17. Hagmar L, Bonassi S, Stromberg U, Mikoczy Z, Lando C, Hansteen I, et al. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat Res 1998b: 405:171-178.
18. Harries LW, Stubbins MJ, Forman D, Howard GCW, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997: 18:641-644.
19. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3:421-428.
20. Johnson KL, Nath J, Pluth JM, Tucker JD. The distribution of chromosome damage, non-reciprocal translocations and clonal aberrations in lymphocytes from Chernobyl clean-up workers. Mutat Res 1999; 439:77-85.
21. Martinez C, Agùndez JA, Olivera M, Martin R, JM L., Benitez J. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 1995; 5:207-214.
22. Matthias C, Brockmuhl U, Jahnke V, Harries LW, Wolf CR, Jones PW, et al. The glutathione 5-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 1998; 8:1-6.
23. Mendelsohn M, Mayall B, Bogart E, Moore D II, Perry B. DNA content of the various radiation-induced chromosomal rearrangements in relation to the dose and sample time. Science 1973; 179:1126-1129.
24. Nyberg F, Hou S, Hemminki K, Lambert B and Pershagen G. Glutathione S-transferase μ1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls. Cancer Epidemiol Biomark Prevent 1998; 7:875-883.
25. Oyama T, Kawamoto T, Mizoue T, Yasumoto K, Kodama Y, Mitsudomi T. N-acetylation polymorphism in patients with lung cancer and its association with p53 gcnc mutation. Anticancer Res 1997; 17:577-581.
26. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B, Taylor JB. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300:271-276.
27. Philip PA, Fitzgerald DL, Cartwright RA, Peake MD, Rodgers HJ. Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis 1988; 9:491-493.
28. Ramsey MJ, Moore DH, Briner JF, Lee DA, Olsen LA, Senft JR, Tucker JD. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mut Res 1995; 338:95-106.
29. Rumsby PC, Yardley-Jones A, Anderson D, Phillimore HE, Davies MJ. Detection of CYP1A1 mRNA levels and CYP1A1 Msp 1 polymorphisms as possible biomarkers of exposure and susceptibility in smokers and non-smokers. Teratogen Carcinogen Mutagen 1996; 16:65-74.
30. Smith CA, Harrison DJ. Association between polymorphism in genes for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350:630-633.
31. Steen VM, Andreassen OA, Daly AK, Tefre T, Borresen A, Idle JR, Gulbrandsen A. Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogetics 1995; 5:215-223.
32. Tucker JD, Moore DH II. The importance of age and smoking in evaluating adverse cytogenetic effects of exposure to environmental agents. Environ Health Perspect 1996: 104 (Suppl 3):489-492.
33. Tucker JD, Ramsey M, Lee D, Minkler J. Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int J Radiat Biol 1993; 64:27-37.
34. Tucker JD, Lee D, Ramsey M, Briner J, Olsen L, Moore D II. On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutat Res 1994; 313:193-202.
35. Tucker JD, Breneman JW, Briner JF, Eveleth GG, Langlois RG, Moore DH II. The persistence of radiation-induced translocations in rat peripheral blood determined by chromosome painting. Environ Mol Mutagen 1997; 30:264-272.
36. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FK, Landi MT, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994; 369:154-156.